Rocío Isabel
Rodríguez Macías
Catedrática de Universidad
Hospital Universitario de Salamanca
Salamanca, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Salamanca (27)
2024
2023
-
Impact of Aberrant β-Catenin Pathway on Cholangiocarcinoma Heterogeneity
Cells, Vol. 12, Núm. 8
-
Relevance of the organic anion transporting polypeptide 1B3 (OATP1B3) in the personalized pharmacological treatment of hepatocellular carcinoma
Biochemical Pharmacology, Vol. 214
-
Role of Intracellular Drug Disposition in the Response of Acute Myeloid Leukemia to Cytarabine and Idarubicin Induction Chemotherapy
Cancers, Vol. 15, Núm. 12
2021
-
Impact of aging on primary liver cancer: epidemiology, pathogenesis and therapeutics
Aging, Vol. 13, Núm. 19, pp. 23416-23434
-
Novel pharmacological options in the treatment of cholangiocarcinoma: Mechanisms of resistance
Cancers, Vol. 13, Núm. 10
2020
-
A novel serum metabolomic profile for the differential diagnosis of distal cholangiocarcinoma and pancreatic ductal adenocarcinoma
Cancers, Vol. 12, Núm. 6
-
Sensitizing gastric adenocarcinoma to chemotherapy by pharmacological manipulation of drug transporters
Biochemical Pharmacology, Vol. 171
2019
-
Causes of hOCT1-Dependent Cholangiocarcinoma Resistance to Sorafenib and Sensitization by Tumor-Selective Gene Therapy
Hepatology, Vol. 70, Núm. 4, pp. 1246-1261
-
Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis
Hepatology, Vol. 70, Núm. 2, pp. 547-562
2018
-
Role of drug transporters in the sensitivity of acute myeloid leukemia to sorafenib
Oncotarget, Vol. 9, Núm. 47, pp. 28474-28485
2015
-
Effect of ursodeoxycholic acid treatment on the altered progesterone and bile acid homeostasis in the mother-placenta-foetus trio during cholestasis of pregnancy
British Journal of Clinical Pharmacology, Vol. 79, Núm. 2, pp. 316-329
2013
-
Protective effects of phenolic constituents from Cytisus multiflorus, Lamium album L. and Thymus citriodorus on liver cells
Journal of Functional Foods, Vol. 5, Núm. 3, pp. 1170-1179
2012
-
Characterization of the role of ABCG2 as a bile acid transporter in liver and placenta
Molecular Pharmacology, Vol. 81, Núm. 2, pp. 273-283
-
Genetic variants in genes involved in mechanisms of chemoresistance to anticancer drugs
Current Cancer Drug Targets, Vol. 12, Núm. 4, pp. 402-438
-
No correlation between the expression of FXR and genes involved in multidrug resistance phenotype of primary liver tumors
Molecular Pharmaceutics, Vol. 9, Núm. 6, pp. 1693-1704
-
Up-regulation of FXR isoforms is not required for stimulation of the expression of genes involved in the lack of response of colon cancer to chemotherapy
Pharmacological Research, Vol. 66, Núm. 5, pp. 419-427
2011
-
Further characterization of the electrogenicity and ph sensitivity of the human organic anion-transporting polypeptides OATP1B1 and OATP1B3
Molecular Pharmacology, Vol. 79, Núm. 3, pp. 596-607
-
Hepatic expression of sodium-dependent vitamin C transporters: Ontogeny, subtissular distribution and effect of chronic liver diseases
British Journal of Nutrition, Vol. 106, Núm. 12, pp. 1814-1825
2008
-
Molecular bases of the fetal liver - Placenta - Maternal liver excretory pathway for cholephilic compounds
Liver International, Vol. 28, Núm. 4, pp. 435-454